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Serine hydroxymethyltransferase (SHMT), a member
of the -class of pyridoxal phosphate-dependent en-
zymes, catalyzes the reversible conversion of serine to
glycine and tetrahydrofolate to 5,10-methylene tetrahy-
drofolate. We present here the crystal structures of the
native enzyme and its complexes with serine, glycine,
glycine, and 5-formyl tetrahydrofolate (FTHF) from Ba-
cillus stearothermophilus. The first structure of the ser-
ine-bound form of SHMT allows identification of resi-
dues involved in serine binding and catalysis. The
SHMT-serine complex does not show any significant
conformational change compared with the native en-
zyme, contrary to that expected for a conversion from an
“open” to “closed” form of the enzyme. However, the
ternary complex with FTHF and glycine shows the re-
ported conformational changes. In contrast to the Esch-
erichia coli enzyme, this complex shows asymmetric
binding of the FTHF to the two monomers within the
dimer in a way similar to the murine SHMT. Comparison
of the ternary complex with the native enzyme reveals
the structural basis for the conformational change and
asymmetric binding of FTHF. The four structures pre-
sented here correspond to the various reaction interme-
diates of the catalytic pathway and provide evidence for
a direct displacement mechanism for the hydroxy-
methyl transfer rather than a retroaldol cleavage.
Serine hydroxymethyltransferase (SHMT;1 EC 2.1.2.1) is a
PLP-dependent enzyme that plays a central role in the one-
carbon metabolism. It catalyzes the reversible inter-conversion
of serine and tetrahydrofolate to glycine and 5,10-methylene
tetrahydrofolate, a key intermediate in the biosynthesis of pu-
rine, thymidine, choline, and methionine (1, 2). In addition to
this physiological reaction, SHMT has also been shown to cat-
alyze THF-independent aldolytic cleavage, decarboxylation,
racemization, and transamination reactions (3). The impor-
tance of SHMT in DNA synthesis coupled with the observed
high level of enzyme activity in rapidly proliferating cells has
focused attention on SHMT as a potential target for the devel-
opment of anticancer and antimicrobial agents (4–6).
Several mechanisms have been proposed for the hydroxy-
methyl transfer, the most favored being the retroaldol cleavage
(7, 8). The crystal structures of human liver SHMT (hcSHMT)
and rabbit liver SHMT (rcSHMT) and Escherichia coli SHMT
(eSHMT) as well as murine cytoplasmic SHMT (mcSHMT)
have been reported (9–12). The structure of a reduced form of
rcSHMT representing a gem diamine equivalent has also been
reported (10). Although these structures have provided a
wealth of information regarding the architecture of the en-
zyme, active site, and residues involved in substrate binding
and catalysis, several aspects of SHMT catalytic mechanism
remain uncertain (7, 13). A detailed comparison and analysis of
several structures of the enzyme corresponding to different
intermediate steps and in complex with various substrates,
substrate analogs, and product analogs are required to unravel
the finer molecular details of the catalytic mechanism. Fur-
thermore, it would be better if these structures could be com-
pared from the same enzyme to eliminate the ambiguities
arising from differences in sequence, crystallization conditions,
and crystal packing. In this paper we describe and compare the
crystal structures of SHMT from Bacillus stearothermophilus
(bsSHMT) in its internal aldimine form, external aldimine
form with bound serine and glycine, and as a ternary complex
with glycine and FTHF. Although the structures of the internal
aldimine form and ternary complex have been reported earlier
(9–12), the external aldimine form with bound serine and gly-
cine are presented in this paper for the first time. A detailed
analysis of bsSHMT structures and a comparison with previ-
ously reported structures allows an accurate determination of
conformational changes in protein structure, orientation of the
PLP ring, and key amino acid residues during different stages
of catalysis. An analysis of these results provides structural
evidence for a direct transfer mechanism for the SHMT cata-
lyzed reaction.
EXPERIMENTAL PROCEDURES
Overexpression and Purification—The SHMT gene was PCR-ampli-
fied from B. stearothermophilus genomic DNA using the following prim-
ers: sense primer, 5-GGGGGAGCTACATATGAACTACTTGCCAC-3,
and antisense primer, 5-GAGCGGAAACGGATCCGTCAAAGCGGC-
GAC-3, containing NdeI and BamHI restriction sites (underlined nu-
cleotides). The primers were designed using the sequence of SHMT gene
from B. stearothermophilus available in the data base (GenBankTM
accession number E02190). The PCR product was digested with NdeI
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and BamHI and cloned into pRSET C vector at the same sites. The
clones were screened by restriction digestion and confirmed by sequenc-
ing. The resulting plasmid designated PR bsSHMT was transferred into
E. coli BL21(DE3) pLysS strain. A single colony was inoculated into 50
ml of LB medium containing 50 g/ml ampicillin and grown overnight
at 30 °C. These cells were used to inoculate 1 liter of terrific broth
medium containing 50 g/ml ampicillin. After 4 h of growth at 30 °C,
the cells were induced with 0.3 mM isopropyl-1-thio--D-galactopyrano-
side for 5 h. The isopropyl-1-thio--D-galactopyranoside-induced cells
were harvested, resuspended in buffer A (50 mM Tris-HCl, pH 7.5, 1 mM
EDTA, 1 mM 2-mercaptoethanol), and sonicated. The supernatant was
loaded on a MonoQ column equilibrated with buffer A. The protein was
eluted using a linear gradient with buffer A containing 1 M NaCl. The
fractions containing the protein were pooled and loaded on a phenyl
Superose column equilibrated with buffer A containing 1 M ammonium
sulfate. The protein was eluted using the same buffer without ammo-
nium sulfate. The fractions containing the protein were pooled and
precipitated using ammonium sulfate (65% saturation). The pellet was
resuspended in buffer B (100 mM Hepes buffer, pH 7.5, 0.2 mM EDTA,
5 mM 2-mercaptoethanol, 100 mM NaCl) and further purified on a
Superdex-200 (Amersham Biosciences) gel filtration column equili-
brated with buffer B. Peak fractions corresponding to the dimer were
pooled and concentrated to 15 mg/ml using a 50-kDa cutoff Centricon
(Amicon).
Crystallization—SHMT protein crystals were grown by hanging drop
vapor diffusion method at 25 °C. Protein crystals were obtained by
mixing 4 l of protein solution with 4 l of reservoir solution containing
100 mM Hepes buffer, pH 7.5, 0.2 mM EDTA, 5 mM 2-mercaptoethanol,
50% 2-methyl-2,4-pentanediol. Crystals started appearing within 4–5
days and grew to a maximum size in 5–10 days. SHMT crystals com-
plexed with serine and glycine were obtained under the same condition
as that of the native protein, except that the reservoir solution con-
tained additional 10 mM serine or glycine. The ternary complex crystal
of SHMT with glycine and 5-formyl tetrahydrofolate (Sigma) were ob-
tained by adding FTHF to the protein solution (2 mM final concentra-
tion) and 10 mM glycine to the reservoir solution. The hanging drops
were incubated for 3 h at 18–20 °C and subsequently transferred to
room temperature (25 °C).
X-ray Diffraction Data Collection and Processing—Crystals were
soaked for a few seconds in a harvesting solution containing 100 mM
Hepes buffer, pH 7.5, 0.2 mM EDTA, 5 mM 2-mercaptoethanol, 50%
2-methyl-2,4-pentanediol, and 25% glycerol and flash-frozen in a nitro-
gen stream (Oxford cryosystems) at 100 K. X-ray diffraction data were
collected on a Rigaku Ru-300 x-ray generator using MAR345 image
plate detector. The HKL suite was used for data reduction and scaling
(14). The native crystals as well as the serine and glycine complex
crystals belonged to the space group P21212 with one monomer in the
asymmetric unit. These crystals diffracted to better than a 2 Å resolu-
tion. Final data sets were collected to a 1.93 Å resolution. The ternary
complex crystals with glycine and FTHF belonged to the space group
P21 with a dimer in the asymmetric unit and diffracted poorly compared
with the native crystals. The final data set was collected to a resolution
of 2.7 Å. Details of cell dimensions and data collection statistics for the
native and various complex crystals are shown in Table I.
Structure Determination and Model Building—Initially the struc-
ture of the internal aldimine form (native form) was determined by
molecular replacement technique. A polyalanine model of the structure
of E. coli SHMT, which shows a sequence identity of 60.8% with the
bsSHMT sequence, served as an excellent search model (Protein Data
Bank entry 1df0). The final model was composed of residues 5–403 of
the E. coli structure, modified by omission of residues 243–245 corre-
sponding to insertion in the E. coli sequence, based on sequence align-
ments using CLUSTALW (15). Rotation and translation searches were
made using the CCP4 (16) program AMoRe (17). Best solutions were
obtained using the data between 10 and 3 Å of resolution. The trans-
formed model was subjected to rigid body refinement using the program
XPLOR (18). The N- and C-terminal domains (residues 5–280 and
281–403) of the model were refined independently during rigid body
refinement. The phases were improved and extended to 1.93 Å of
resolution by solvent flattening using the program DM (19). These
phases were used to calculate a 2Fo  Fc map and visualized using the
graphics program TURBO-FRODO (20). The map was readily interpret-
able, and the electron density for the PLP cofactor, which was omitted
from the model, was clearly visible. Most of the side chains were built
into the map, and the model was refined using maximum likelihood
positional refinement in REFMAC, with restrained temperature factors
(21). After each cycle of refinement, manual rebuilding was performed
wherever necessary, and previously undefined side chains were built
into the electron density map. The PLP molecule from the eSHMT
structure was manually adjusted and built into the electron density
map. Solvent molecules were added during final cycles of refinement.
The crystallographic free R-factor (22) was monitored at each stage to
prevent model bias. The quality of the structure was evaluated using
the Ramachandran plot and the program PROCHECK (23). Statistics
on the final model are presented in Table I.
The electron density maps for the serine and glycine complex crystals
were computed using data to a 1.93 Å resolution from these crystals and
refined phases from the native SHMT model without PLP and solvent
molecules. The models for the serine- and glycine-bound form were
subsequently refined in the same manner as the native form. The model
for the ternary form with bound glycine and FTHF was obtained by
molecular replacement searches using the native form as the search
model. The two monomers in the asymmetric unit were subjected to
rigid body refinement before manual model building and subsequent
refinement. Strict non-crystallographic symmetry restraints (tight re-
straints for main chain and medium restraints for the side chain) were
applied during refinement. The non-crystallographic symmetry re-
straints were gradually reduced and completely relaxed during the final
round of refinement. Although one of the subunits showed a good
electron density for the bound FTHF molecule, the other subunit re-
vealed a much weaker density for the FTHF, and there was no appre-
ciable density for the monoglutamate side chain. Initially the FTHF
molecule from the E. coli structure was manually adjusted and built
into the electron density map for the subunit, showing good density for
the bound FTHF. During the final stages of refinement, part of the
FTHF molecule (without the monoglutamate side chain) for the other
subunit was also included in the model.
Comparison of the bsSHMT structures and earlier reported struc-
tures were carried out by manual superposition followed by rigid body
refinement option in TURBO-FRODO as well as with the CCP4 pro-
gram LSQKAB. Differences between the structures were detected visu-
ally and by calculating the distances between corresponding C atoms.
Differences in the orientation of the PLP ring were calculated using the
CCP4 program GEOMCALC.
RESULTS
SHMT Structure—The final model of bsSHMT consists of
405 (1–405) residues, including the N-terminal methionine.
Seventeen residues were inserted at the C terminus due to the
cloning strategy employed. These residues were not visible in
the electron density map and, consequently, were not included
in the final model. The overall fold of the native enzyme is very
similar to that of other known SHMT structures and other
PLP-dependent enzymes of the -class, such as aspartate ami-
notransferase. Briefly, the monomer fold comprises two major
domains, the N-terminal domain (residues 1–279) and a C-
terminal domain (280–405). The N-terminal domain can be
further divided into two sub-domains, a small N-terminal sub-
domain (residues 1–80) and a larger PLP binding domain (res-
idues 81–279). The small N-terminal domain comprises three
FIG. 1. The overall fold of the dimer of native bsSHMT, pre-
pared using the program MOLSCRIPT (41). The cofactor PLP is
shown in the ball and stick representation.
Crystal Structure of Serine Hydroxymethyltransferase17162
 by guest, on August 2, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
-helices and one -strand, whereas the larger N-terminal
domain folds into an  structure consisting of a seven-
stranded mixed -sheet flanked by -helices on both sides. The
C-terminal domain folds into an  sandwich. All the SHMTs
studied to date are either homodimers or homotetramers, the
dimer being the minimum structure necessary for the catalytic
activity. The four known structures of SHMT (hc-, rc-, mc-, and
eSHMT) are all reported to be tetramers, although the quater-
nary organization of eSHMT structure is different from the
mammalian SHMT structures (9–12). In contrast, the quater-
nary structure of bsSHMT is a dimer. The crystallographic
asymmetric unit consists of a monomer, and the two monomers
of the dimer are related by the crystallographic symmetry. No
tetrameric contacts are visible in the crystal structure. This is
consistent with the gel filtration experiments (data not shown),
which shows that the protein elutes at a position corresponding
to a dimer. The overall structure of the bsSHMT is depicted in
Fig. 1.
Serine and Glycine External Aldimine Complexes—The
structures of the serine and glycine complexes of bsSHMT are
virtually identical to that of the native enzyme except for local
conformational changes involving the PLP ring and side-chain
atoms in the active site region. When compared with the native
structure, the serine and glycine complexes show a root mean
FIG. 2. Electron density around the
cofactor PLP and serine at the active
site of bsSHMT serine complex. The
electron density shown is from a Fo  Fc
omit map calculated from the final re-
fined phases. Some of the key residues at
the active site are shown in stick repre-
sentation. The figure was prepared using
TURBO-FRODO.
FIG. 3. Stereoview of the superposi-
tion of active site regions in the in-
ternal aldimine and external aldi-
mine structures of bsSHMT showing
the rotation of the PLP ring and con-
formational change in the Tyr-61 res-
idue. The carbon atoms belonging to the
internal aldimine and external aldimine
structures are shown in dark green and
light green colors, respectively. The nitro-
gen atoms are shown in blue, oxygen at-
oms are shown in red, and phosphorous
atoms are shown in magenta. The figure
was prepared using the program MOL-
SCRIPT (41).
TABLE I
Statistics for data collection and structure determination
r.m.s.d., root mean square deviation.
Native Serine Glycine Ternary
Cell dimensions A˚ a  61.15 a  60.98 a  61.27 a  57.42
b  106.64 b  106.28 b  106.40
b  104.61
c  56.86 c  56.89 c  56.99
c  62.49
  91.43°
Data collection statistics
Resolution A˚ 1.93 1.93 1.93 2.70
Completeness (%) 97 96.9 97.6 95.3
Total reflections 68,643 69,596 80,764 53,510
Unique reflections 27,746 27,573 27,979 19,264
Rsym % 3.1 3.7 4.3 5.3
Refinement statistics
Resolution range A˚ 10–1.93 10–1.93 10–1.93 10–2.70
Final R-factor (all data) (%) 17.86 17.90 16.98 20.84
Rfree (%) 20.34 20.59 19.73 23.61
r.m.s.d. (bonds) A˚ 0.009 0.009 0.008 0.009
r.m.s.d. (angles) A˚ 0.026 0.025 0.025 0.023
Model statistics
Protein atoms 3,116 3,116 3,116 6,232
Substrate and cofactor
atoms
15 22 20 103
Water molecules 226 238 245 57
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square deviation of 0.11 and 0.13 Å, respectively, over the 405
superposed C atoms. Several studies have suggested that
SHMT undergoes a conformational change upon binding of
substrates with a 3-hydroxyl group, resembling the transition
that occurs in aspartate aminotransferase from an “open” to
“closed” form on binding of the aspartate or 2-methylaspartate
substrates (24–26). Thermal stability of the SHMT increases
upon binding of serine, and this change in thermal stability of
the enzyme has been attributed to a conformational change in
SHMT, like that in aspartate aminotransferase (27–30). The
crystal structures of mcSHMT and eSHMT complexed to gly-
cine and FTHF indeed show a conformational change compared
with the unliganded hc- and rcSHMT structures. However, the
observed conformational changes have been largely attributed
to the binding of the amino acid substrate (11). The structures
of serine and glycine aldimine forms of bsSHMT clearly show
that the amino acid substrate binding alone does not induce
significant conformational changes in the protein. The confor-
mational changes observed earlier could be a result of FTHF
binding. The reported thermal stability of the enzyme is most
likely due to the interaction of the serine with the enzyme,
particularly those that bridge the two monomers of the dimer,
and filling the active site cavity.
The electron density for the bound amino acid substrates was
very clear, allowing the substrate to be placed unambiguously.
The electron density around the bound serine substrate is
shown in Fig. 2. The PLP ring in the serine complex rotates by
24° (primarily around the C5-C5 bond) compared with its
internal aldimine form (Fig. 3). A similar rotation of the PLP
ring has been reported for aspartate aminotransferase (25°)
and between the reduced and unreduced forms of rcSHMT
structures (31, 32, 10). In contrast, only a small rotation of the
PLP ring (8°) has been reported in the E. coli ternary complex
structure relative to the unliganded hc- and rcSHMT struc-
tures (11). However, the PLP ring in the E. coli structure shows
a rotation of about 21° compared with the native form of
bsSHMT. The orientation of the PLP is very similar between
the two external aldimine forms of the bsSHMT, except for
minor movements in the serine complex, to accommodate the
FIG. 4. Stereoview of the overlaid
structures of the monomer A (show-
ing good density for the FTHF) of
bsSHMT ternary complex (red) and
the native structure (green) showing
differences in the conformations of
the C-terminal domain and parts of
the N-terminal domain. The program
MOLSCRIPT (41) was used to prepare
this figure.
FIG. 5. Stereoview of the active site region in the monomer A of bsSHMT ternary complex showing the FTHF and key residues
interacting with the FTHF molecule. The figure was prepared using the program MOLSCRIPT (41).
TABLE II
Interactions of the FTHF in the monomer A and monomer B of the
ternary complex structure of bsSHMT
FTHF atom Protein residue Atom Monomer A Monomer B
A˚ A˚
N1 Asn-341 ND2 3.49 3.64
N2 Leu-117 AO 2.95 3.00
N2 Gly-120 AO 3.18 3.94
N2 Gly-121 AO 2.93 3.37
N3 Gly-121 AO 2.60 2.89
O4 Leu-123 N 2.79 2.88
O5 Glu-53 OE1 2.51 2.87
O5 Glu-53 OE2 2.58 2.61
N8 Asn-341 OD1 2.76 2.99
N10 Glu-53 OE2 3.19 3.37
OE1 Ser-349 OG 3.00
OE1 Phe-351 N 3.40
O1 Tyr-60 OH 2.49
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additional interactions due to the hydroxyl group of the serine.
The bound serine substrate makes several interactions with
both the monomers of the protein. The bound glycine shows
exactly the same interactions, except for those formed by the
hydroxyl group of the serine. The hydroxyl group of serine is in
close proximity of the carboxylate group of GluB53 (2.5 Å). It is
also within hydrogen-bonding distance from the imidazole
group of HisA122 (2.80 Å). The carboxylate group of serine
forms a tight ion pair with ArgA357. In addition, one of the
oxygen atoms of the carboxylate group also interacts with the
imidazole of HisA200, and the other can form hydrogen bonds
with the side chains of SerA31 and TyrB61. An interesting
conformational change observed is that of Tyr-61 (Fig. 3). In
the native structure, the side chain of TyrB61 is within hydro-
gen-bonding distance from ArgA357 (2.72 Å), away from
GluB53 (5 Å). However, in the serine complex, it flips toward
GluB53, away from ArgA357, presumably due to the interac-
tion of the substrate carboxylate group with ArgA357. This
conformational change leads to new interaction of TyrB61 with
GluB53 and serine carboxylate group and brings the hydroxyl
group of TyrB61 close to the C of serine (2.81 Å).
The Ternary Complex—The ternary complex of bsSHMT
with bound glycine and FTHF shows small but significant
conformational changes compared with the native structure,
similar to that observed in the structures of mc- and eSHMT
(11, 12). A remarkable feature of the ternary complex structure
of bsSHMT is the lack of structural symmetry and differences
in the FTHF interaction between the two monomers of the
dimer. Although one of the monomers showed a strong density
for the FTHF molecule (monomer A), the other monomer re-
vealed a much weaker density, and there was no appreciable
density for the monoglutamate part of the molecule in that
monomer (monomer B; see “Discussion”).
The first clue toward the asymmetry between the two mono-
mers came from the breakdown of orthorhombic symmetry in
the crystals of the ternary complex. The crystals of the native
and aldimine forms belong to the orthorhombic system with a
monomer in the asymmetric unit, whereas the ternary complex
crystals belong to the monoclinic system, with a dimer in the
asymmetric unit, although the cell dimensions were not very
different from the other three forms (Table I). When compared
with the native form, both the monomers of the ternary com-
plex show movements in the C-terminal domain (residues 280–
405) and parts of the N-terminal domain, particularly around
the active site region. The difference between the two mono-
mers of the dimer in the ternary complex appear to be mainly
in the extent of these movements. A comparison of the mono-
mer A (showing good density for FTHF) of the bsSHMT ternary
complex to the native structure shows a difference of about 4°
in the hinge angle between the N- and C-terminal domains,
whereas this difference is only 2.5° in the monomer B.
A superposition of the monomer A of the bsSHMT ternary
complex with the native structure is shown in Fig. 4. Apart
from an overall movement of the C-terminal domain, the ter-
nary complex structure reveals most obvious differences in the
region of residues 315–330 and 342–352 of the C-terminal
domain and, to a lesser extent, in the regions 27–31 and 114–
118 of the N-terminal domain compared with the native struc-
ture. Differences in similar regions have been reported in the
structures of the ternary complexes of the mc- and eSHMT (11,
12). The carboxylate group of glycine substrate interacts with
the hydroxyl group of Ser-31. Furthermore, the region of resi-
dues 27–31 is sandwiched between the regions 336–339 and
358–362 of the C-terminal domain. The interaction of Ser-31
FIG. 6. The overlaid structures of
the native form and the ternary com-
plex (monomer A) of bsSHMT around
the monoglutamate binding site. The
difference in the conformations of the loop
region (residues 342–352) is depicted. The
monoglutamate side chain of FTHF steri-
cally clashes with the Phe-351 residue of
the native structure unless this region is
moved away from the monoglutamate
binding site. The carbon atoms belonging
to the native and ternary complex struc-
tures are shown in dark green and light
green colors, respectively. The nitrogen
atoms are shown in blue, and oxygen at-
oms are shown in red. The figure was
prepared using the program MOL-
SCRIPT (41).
TABLE III
Interactions of the PLP group in the four structures of bsSHMT
PLP atom Protein residue Atom Native Serine complex Glycine complex
Ternary complex
Monomer A Monomer B
A˚ A˚ A˚ A˚
N1 Asp-197 OD2 2.58 2.66 2.63 3.18 2.99
O3 Lys-226 NZ 2.69
O3 His-200 ND1 3.00 3.20 3.14 3.18 2.94
O3 Ser-172 OG 3.01 2.62 2.60 2.85 2.86
OP1 Ala-95 N 2.85 2.88 2.87 3.03 3.09
OP1 Ser-93 OG 3.58 3.75 3.68 2.93 3.30
OP2 Thy-51B OH 2.45 2.46 2.48 2.70 2.56
OP2 Gly-257B N 2.95 2.90 2.95 3.06 3.19
OP3 Gly-94 N 3.09 3.01 3.06 3.23 3.26
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with the carboxylate group of glycine substrate appears to
cause a small movement in this region, which is further en-
hanced by the overall movement of the C-terminal domain. The
exocyclic nitrogen of the pteridine ring of FTHF interacts with
the main chain carbonyl oxygens of the residues Leu-117, Gly-
120, and Gly-121, inducing a small movement in the region
114–119. The position of the loop region 342–352 appears to be
important for the FTHF binding. The major difference between
the two monomers of bsSHMT appears to be in this loop region.
The structural basis for the conformational change in the pro-
tein as well as the asymmetric binding of the FTHF will be
discussed in the next section.
The bound FTHF molecule is involved in several interactions
with the protein. Briefly, the carboxylate group of Glu-53 in-
teracts with the formyl oxygen atom and the N10 atom of the
FTHF. The side chain of Asn-341 is within hydrogen-bonding
distance from N1 and N8 atoms of the pteridine ring. The C2
amino group of FTHF interacts with the main chain carbonyl
oxygen atoms of residues Leu-117, Gly-120, and Gly-121. The
main chain carbonyl oxygen of the residue Gly-121 and the
amide group of the residue Leu-123 forms hydrogen bonds with
the N3 and O4 atoms of FTHF molecule. The p-aminobenzoic
acid moiety of the FTHF stacks against the side chain of Tyr-
60. The monoglutamate part of the molecule makes only one
significant interaction with the hydroxyl group of Ser-349 (only
in monomer A). A stereo view of the FTHF binding site is
shown in Fig. 5, and details of the interactions made by FTHF
in both the monomers are presented in Table II. The overall
position and orientation of FTHF molecule in bsSHMT is sim-
ilar to that in the E. coli structure. Between the two monomers
of bsSHMT, the pteridine ring and the phenyl ring of the FTHF
reveal small displacements, and there was no density for the
monoglutamate part of the FTHF in the monomer B. The
average temperature factor associated with the FTHF in mon-
omer B (45) was higher when compared with that in mono-
mer A (37). Furthermore, the interactions of FTHF in mono-
mer B are much weaker compared with those in monomer A
(Table II).
PLP Binding Site—Details of interactions made by the PLP
in the four structures of bsSHMT are presented in Table III.
The overall environment of the PLP, including the interacting
protein ligand groups and the ring stacking histidine, is very
similar to that found in the known SHMT structures (9–12). It
is clear from Table III that these interactions are mostly con-
served during different intermediate steps of the catalytic cy-
cle. The interaction of the N atom of the Lys-226 with the
Thr-223 is particularly interesting. The Thr-223 (226 in eS-
HMT) has been implicated in stabilizing the external aldimine
form based on mutational studies (33), which was further con-
firmed by the crystal structures. In the external aldimine struc-
tures of bsSHMT, Lys-226 forms strong hydrogen-bonding in-
teraction with this residue (2.89 Å), similar to that in the
eSHMT structure. However, in the ternary complex, this inter-
action is much weaker, particularly in the monomer B (3.17 Å),
and instead, a stronger interaction is made between Lys-226
and TyrB51 (2.8 Å). Tyr-51 appears to play a role in the con-
FIG. 7. Stacking interaction made
by His-108 residues in the bsSHMT
structure and His-135 residues in the
mcSHMT structure. a, stereoview of the
region around the His-108 residues at
the dimer interface of bsSHMT. b, stereo-
view of the region around the His-135 res-
idues at the tetramer interface of the mc-
SHMT structure. The His-135 residues in
the four subunits are labeled as A, B, C,
and D. The figure was prepared using the
program MOLSCRIPT (41).
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version of the enzyme from its internal aldimine to the external
aldimine form, apart from Thr-223.
DISCUSSION
Structural Basis for the Conformational Changes and Asym-
metric Binding of the FTHF—The crystal structures of the
ternary complexes of E. coli, murine, and bsSHMT clearly
establish a small but significant conformational change in the
protein compared with the native form, similar to those ob-
served in aspartate aminotransferase (11, 12, 34). In all three
structures, the C-terminal domain moves relative to the N-
terminal domain, and most obvious differences are observed in
the loop region 342–352 (390–400 in mcSHMT, around 350 in
eSHMT). The position of this loop appears to be important for
the binding of the folate cofactor. Although it was suggested in
the mcSHMT structure that the binding of the folate induces a
shift in this region, the structural requirement for such a
movement was unclear (12). A superposition of the ternary
complex of bsSHMT with the native form reveals that the side
chain of Phe-351 in the native structure sterically prevents the
monoglutamate side chain of the FTHF from binding in that
position unless the loop is moved away from that region (Fig.
6). The monoglutamate side chain of the FTHF molecule in the
bsSHMT (monomer A) occupies the same position as the side
chain of Phe-351 in the native structure, necessitating a move-
SCHEMES I and II. Schematic representation of the mechanisms proposed for the reaction catalyzed by SHMT. I, retroaldol cleavage
mechanism; II, direct displacement mechanism.
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ment of this region away from the monoglutamate binding site.
The interaction of Asn-341 with N1 and N8 atoms of the pter-
idine ring appears to facilitate the shift in this loop position.
The spectral and titration calorimetric studies on the rc-
SHMT have indicated that the ternary complex of the enzyme
with glycine and FTHF exists in equilibrium consisting of
quinonoid, external aldimine, and gem diamine forms (3, 25,
35), which is confirmed by the crystal structure of the mcSHMT
(12). In the mcSHMT structure, the two obligate dimers form-
ing the tetramer reveal asymmetric binding of the FTHF, and
a loop region (B154-B160) has been implicated in this (12). In
contrast, all the active sites of the two dimers in the eSHMT
appear to bind glycine and FTHF in a very similar manner (11).
The differences in the FTHF binding properties of the murine
and E. coli SHMT has been attributed to the tetrameric nature
of the mammalian enzyme and critical residues in the tet-
rameric contact region, which are lacking in the E. coli enzyme
(12). The bsSHMT ternary complex exhibits asymmetric bind-
ing of FTHF despite being a dimeric enzyme and lacking the
residues corresponding to the loop region 154–160 in the mu-
rine structure. The most likely candidate causing the asymmet-
ric binding of FTHF in bsSHMT appears to be the stacking
interaction of the imidazole ring of His-108 from the two mono-
mers at the dimer interface of the molecule (Fig. 7). The bind-
ing of the folate cofactor results in a small shift in the region
114–119. This movement could be transmitted to the same
region of the other subunit via the stacking interaction of the
His108 from the two monomers. In other words the displace-
ment in the region 114–119 of the monomer A prevents a
similar movement in the monomer B, affecting the binding of
FTHF in the monomer B. In the mcSHMT structure, a similar
stacking interaction was observed involving His-135 residues
(equivalent of His-108) belonging to the two dimers (A-C, B-D)
of the tetramer. It is interesting to note that although the
asymmetry is found between the two monomers of the dimer of
bsSHMT, it is observed between the two obligate dimers of the
mcSHMT. In eSHMT on the other hand, which does not exhibit
asymmetry in FTHF binding, the residue corresponding to
His-108 is a proline (P112), and consequently, no stacking
interaction is observed in that structure.
Mechanistic Implications—Several reaction mechanisms
have been proposed for the cleavage and transfer of the hy-
doxymethyl group of serine, the favored mechanism being the
retroaldol cleavage (7). The retroaldol cleavage mechanism
(Scheme I) requires a catalytic base to abstract a proton from
the -hydroxyl group of serine and a favorable conformation of
the bound substrate for the cleavage reaction to occur. The
structure of bsSHMT serine complex reveals two possible can-
didates for the base, which abstracts a proton from the hy-
droxyl group of the serine. The side chain carboxylate of Glu-53
and the imidazole group of His-122 (stacking with PLP) are in
close proximity of the hydroxyl group of the serine. The side
chain carboxylate of Glu-53 has been reported to be in its acid
form (protonated), not the conjugated base, in the crystal struc-
ture of eSHMT (11). The interaction of Glu-53 in the structure
of bsSHMT further confirms this observation. The Glu-53 in-
teracts with 5-formyl oxygen of FTHF in the ternary complex
and with immobilized water molecules in the native glycine
aldimine as well as in the ternary complex structures of
bsSHMT, indicating that it is in its protonated form. Mutation
of the equivalent residue in scSHMT (E74Q) has suggested that
this residue is not involved in proton abstraction (36). If Glu-53
is in a protonated state, then the only other candidate for the
base involved in proton abstraction is His-122. A substantial
amount of activity is retained upon mutation of the correspond-
ing residue in sheep liver cytosolic SHMT (H147N), and this
residue has been implicated in PLP binding rather than proton
abstraction (37). The most favored conformation for this type of
cleavage reaction is an antiperiplanar geometry of the atoms
involved in electron movement (38). However, the geometry at
the C atom of the serine substrate in the external aldimine
complex of bsSHMT is not antiperiplanar, instead showing a
N-C-C-O dihedral angle of 40°, which is not most favorable
for the retroaldol cleavage. Thus, the lack of suitable base for
proton abstraction as well as the unfavorable conformation of
the bound serine suggests the need to consider alternative
mechanisms for catalysis more seriously.
The absence of a cysteine residue in close proximity of the
active site clearly rules out the possibility of a thiohemiacetal
mechanism, which involves nucleophilic attack of a cysteine
residue on the -carbon of the serine. Another possible mech-
anism is the direct displacement of the C bond of the serine
aldimine by the phenolate ion of the Tyr-61 residue, leading to
the formation of a hemiacetal intermediate. As discussed ear-
lier, Tyr-61 residue undergoes a conformational change upon
serine binding and approaches the C atom of the serine (2.8
Å). However, this type of nucleophilic substitution mechanism
(SN2 attack) requires that the nucleophile attacks the carbon
atom from the side opposite bond to the leaving group at an
angle roughly 180° to the carbon bond of the leaving group (39).
The hydroxyl group of Tyr-61 in bsSHMT makes an angle
C-C-O of 94°, which is orthogonal to the carbon bond of the
leaving group and, therefore, not favorable for such a mecha-
nism. Furthermore, mutation analysis of the corresponding
residue in the eSHMT as well as sheep liver cytosolic SHMT do
not suggest the formation of a hemiacetal intermediate (36, 40).
However, the structures of the bsSHMT with serine and ternary
complex favors a direct attack of the THF on the serine aldimine
(direct displacement mechanism; Scheme II). Assuming no fur-
ther changes in the position or conformation of the bound serine,
a superposition of the serine and ternary complex structures
reveals a distance of 2.5 Å between the N5 atom of FTHF and the
-carbon of the serine, optimal for a nucleophilic attack. Further-
more, the angle for nucleophilic attack in this model (as deter-
mined by the angle N5-C-C) is 135°. Both the distance and
angle are appropriate for a direct attack by the N5 atom of THF
at the -carbon of the serine aldimine. Taken together, these
results appear to favor a direct displacement mechanism for the
conversion of serine to glycine by SHMT. However, the THF-
independent cleavage of other -hydroxyamino acids could still
proceed by a retroaldol cleavage mechanism.
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